Several major corporations released their 2025 financial results, showing varied performance. Tui reported stable revenue and growth in cruises and holiday experiences. AstraZeneca and Novo Nordisk faced challenges with sales forecasts amid pricing pressures. Shell and BP experienced profit declines due to falling oil prices, with Shell increasing debt to sustain shareholder payouts. Exxon posted a solid quarter despite lower revenue. The results highlight ongoing industry shifts and economic pressures as 2026 begins.